Lupin informs about press release

05 Jun 2024 Evaluate
Lupin has enclosed a Press Release as regards completion of acquisition by Lupin Atlantis Holdings SA, Switzerland, wholly owned subsidiary of the Company, of two well-known brands, AaraneTM in Germany and NalcromTM in Canada and the Netherlands, along with the associated trademark rights, from Sanofi. This disclosure pursuant to Regulation 30 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2079.50 0.00 (0.00%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×